Singapore - English - HSA (Health Sciences Authority)

progress healthcare pte. ltd. - general hospital - to provide first aid treatment for burns, by cooling, soothing and relieving pain, prior to obtaining medical care. it is a water based gel formulation which does not contain any medicinal product.

Australia - English - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - potassium acetate, quantity: 1.28 g/l; sodium chloride, quantity: 2.34 g/l; magnesium acetate tetrahydrate, quantity: 320 mg/l; glucose, quantity: 50 g/l - injection, intravenous infusion - excipient ingredients: water for injections; hydrochloric acid - plasma-lyte 56 and 5% glucose iv infusion is indicated as a source of water, electrolytes and calories or as an alkalinising agent. plasma-lyte 56 in 5% glucose is indicated as a source of water and electrolytes or as an alkalinising agent.

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - diclofenac sodium - gel - diclofenac sodium 1 % - diclofenac - diclofenac - self medication for the following indications: local treatment of pain, inflammation and swelling due to: • pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.by physicians order :• pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - buprenorphine hcl; naloxone hcl - tablet, orally disintegrating - 2.16mg - buprenorphine hcl 2.16mg; naloxone hcl 0.61mg

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - buprenorphine hcl; naloxone hcl - tablet, orally disintegrating - 8.64mg - buprenorphine hcl 8.64mg; naloxone hcl 2.44mg

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - buprenorphine hcl eqv buprenorphine - tablet - 0.4 mg - buprenorphine hcl eqv buprenorphine 0.4 mg

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - buprenorphine hcl eqv buprenorphine - tablet - 2 mg - buprenorphine hcl eqv buprenorphine 2 mg

Singapore - English - HSA (Health Sciences Authority)

zuellig pharma pte. ltd. - buprenorphine hcl eqv buprenorphine - tablet - 8 mg - buprenorphine hcl eqv buprenorphine 8 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - azacitidine, quantity: 100 mg - injection, powder for - excipient ingredients: mannitol - azacitidine accord is indicated for the treatment of patients with,? intermediate-2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss), ,? chronic myelomonocytic leukemia (cmmol (10-29 percent marrow blasts without myeloproliferative disorder)), ,? acute myeloid leukemia (aml) with 20-30 percent blasts and multi-lineage dysplasia, according to world health organisation classification (who), ,in whom allogenic stem cell transplantation is not indicated.

Australia - English - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - pregabalin, quantity: 150 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; purified talc; sodium lauryl sulfate; gelatin; purified water; titanium dioxide; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pregabalin intas (pregabalin) is indicated for the treatment of neuropathic pain in adults.,pregabalin intas (pregabalin) is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation.